[MO/URSA-QUALITY] URSA-QUALITY-SPC2: Statin Therapy for ASCVD Patients (SPC2)
- 18 Jul 2025
- 1 Minute to read
- Print
- DarkLight
[MO/URSA-QUALITY] URSA-QUALITY-SPC2: Statin Therapy for ASCVD Patients (SPC2)
- Updated on 18 Jul 2025
- 1 Minute to read
- Print
- DarkLight
Article summary
Did you find this summary helpful?
Thank you for your feedback!
Object Description
Among patients with atherosclerotic cardiovascular disease, the percentage who remained on a high-intensity or moderate-intensity statin medication for at least 80% of the treatment period in the last 12 months. Unadjusted Certified Measure da88ce42-9d33-4fe2-a7ca-de989d786bb1
Metadata
- Table Name: ursa.mo_ursa_quality_spc2
- Layer: MEASURE_OBJECT
- Object Type: Measure Object
- Temporal Class: Event
- Case ID: Patient ID, Output NCQA Payer Type Code, Snapshot Date
- Event Date: Snapshot Date
- Primary Key: Ursa Serial ID
Published Fields
Measure Fields
- Denominator
- Numerator
[No Field Group]
- Ursa Serial ID
Was this article helpful?